Enveric Biosciences has received a Notice of Allowance (NoA) from the United States Patent and Trademark Office (USPTO) for a patent application involving EB-373, the company’s...
A report has revealed that the consumption of ayahuasca is increasing in several countries.
The University of Exeter, UK, has launched the world’s first post-graduate course on psychedelics.
Drug Science has launched a new consultancy arm with an emphasis on the emerging cannabis and psychedelic medicine markets.
Following all the hype generated about the therapeutic powers of psychedelics by Michael Pollan’s 2018 book How to Change Your Mind and follow up 2022 Netflix...
A new initiative, the PsychedeliCare Initiative, will launch in 2024 to bring citizens together to educate about psychedelics, call for the reshaping of drug policy and...
The placebo effect is the mysterious power our minds have to make us feel better, even when we are taking just a sugar pill instead of...
MIND Foundation’s INSIGHT Conference took place from August 31 to September 3 in Berlin, exploring the latest frontiers in psychedelic medicines – from clinical developments to...
A team of researchers has analysed the experience of people with Obsessive-Compulsive Disorder (OCD) who have taken psychedelics, finding 30% experienced relief from their symptoms.
Psychedelics have specific drug actions, such as inducing structural and functional neural plasticity, that could potentially treat mental health conditions and impact diseases affecting the brain,...
